Gupta Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$637K Sell
22,648
-1,536
-6% -$43.9K 0.15% 121
2015
Q4
$741K Sell
24,184
-10,533
-30% -$331K 0.19% 107
2015
Q3
$1.03M Sell
34,717
-2,235
-6% -$71.7K 0.25% 86
2015
Q2
$1.18M Buy
36,952
+5,453
+17% +$178K 0.29% 77
2015
Q1
$1.04M Buy
+31,499
New +$1M 0.31% 80

Other funds holding PFE

Gupta Wealth Management's PFE Position: Q1 2016 in Review

Gupta Wealth Management reduced its Pfizer (PFE) stake by 6.4% in Q1 2016, selling an estimated $43.9K and leaving 22,648 shares worth $637K. The position accounts for 0.15% of the portfolio, ranked #121.

Gupta Wealth Management first reported a position in PFE in Q1 2015 and has held it in 5 quarters since. The position peaked at $1.18M in Q2 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Gupta Wealth Management held 22,648 shares of Pfizer worth $637K as of Q1 2016.
  • Gupta Wealth Management sold 1,536 Pfizer shares in Q1 2016, an estimated $43.9K.
  • Pfizer made up 0.15% of Gupta Wealth Management's portfolio in Q1 2016, its #121 holding.
  • Gupta Wealth Management first reported a position in Pfizer in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Pfizer position peaked at $1.18M in Q2 2015.
  • 1,969 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.